The expression of beta-microseminoprotein is found to be decreased in prostate cancer; urinary MSMB has been found to be superior than urinary PSA at differentiating men with prostate cancer at all Gleason grades.
Finally urinary MSMB has been found to be superior than urinary PSA at differentiating men with prostate cancer at all Gleason grades. The expression of beta-microseminoprotein is found to be decreased in prostate cancer.
The expression of beta-microseminoprotein is found to be decreased in prostate cancer. Finally urinary MSMB has been found to be superior than urinary PSA at differentiating men with prostate cancer at all Gleason grades.
The expression of beta-microseminoprotein is found to be decreased in prostate cancer. Finally urinary MSMB has been found to be superior than urinary PSA at differentiating men with prostate cancer at all Gleason grades.